HRMY vs. CTLP

Last updated Jun 13, 2026

HRMY (Harmony Biosciences Holdings, Inc.) and CTLP (Cantaloupe, Inc.) are both stocks. HRMY operates in Biotechnology (Healthcare), while CTLP operates in Information Technology Services (Technology). At a 0.24 correlation, their price movements are largely independent.

Performance

HRMY vs. CTLP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and Cantaloupe, Inc. (CTLP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HRMY

• 1D: -2.10%
• 1M: 12.03%
• YTD: -7.91%
• 6M: -14.93%
• 1Y: 4.52%
• 3Y*: -1.66%
• 5Y*: 1.50%
• 10Y*: —

CTLP

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HRMY vs. CTLP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
HRMY Harmony Biosciences Holdings, Inc.	-7.91%	8.75%	6.53%	-41.38%	29.22%	17.95%	-9.60%
CTLP Cantaloupe, Inc.	5.46%	11.67%	28.34%	70.34%	-51.01%	-15.27%	34.36%

Correlation

The correlation between HRMY and CTLP is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (All Time) Calculated using the full available price history since Aug 19, 2020	0.24

The correlation between HRMY and CTLP shifts across timeframes, from 0.12 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS HRMY : $2.48 CTLP : $0.07
PE Ratio HRMY : 13.88 CTLP : 167.76
PEG Ratio HRMY : 0.14 CTLP : 0.00
PS Ratio HRMY : 2.25 CTLP : 1.93
Total Revenue (TTM) HRMY : $899.11M CTLP : $320.82M
Gross Profit (TTM) HRMY : $688.25M CTLP : $92.41M
EBITDA (TTM) HRMY : $221.74M CTLP : $24.24M

Return for Risk

HRMY vs. CTLP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRMY

HRMY Risk / Return Rank: 44
HRMY Sharpe Ratio Rank: 46
HRMY Sortino Ratio Rank: 41
HRMY Omega Ratio Rank: 43
HRMY Calmar Ratio Rank: 45
HRMY Martin Ratio Rank: 44

CTLP

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRMY vs. CTLP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Cantaloupe, Inc. (CTLP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HRMY	CTLP	Difference
Sharpe ratio: Return per unit of total volatility	0.08	—	—
Sortino ratio: Return per unit of downside risk	0.39	—	—
Omega ratio: Gain probability vs. loss probability	1.06	—	—
Calmar ratio: Return relative to maximum drawdown	0.10	—	—
Martin ratio: Return relative to average drawdown	0.18	—	—

Drawdowns

Drawdown Indicators

	HRMY	CTLP	Difference
Max Drawdown Largest peak-to-trough decline	-68.48%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-34.49%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-50.81%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-68.48%	—	—
Current Drawdown Current decline from peak	-43.42%	—	—
Average Drawdown Average peak-to-trough decline	-35.27%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	18.73%	—	—

Volatility

Volatility by Period

	HRMY	CTLP	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.05%	—	—
Volatility (6M) Calculated over the trailing 6-month period	30.44%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	42.03%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.13%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	52.45%	—	—

Dividends

HRMY vs. CTLP - Dividend Comparison

Neither HRMY nor CTLP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

HRMY vs. CTLP - Profitability Comparison

The chart below illustrates the profitability comparison between Harmony Biosciences Holdings, Inc. and Cantaloupe, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

HRMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 170.88M and revenue of 215.39M. Therefore, the gross margin over that period was 79.3%.

CTLP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cantaloupe, Inc. reported a gross profit of 0.00 and revenue of 78.69M. Therefore, the gross margin over that period was 0.0%.

HRMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 37.29M and revenue of 215.39M, resulting in an operating margin of 17.3%.

CTLP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cantaloupe, Inc. reported an operating income of -767.00K and revenue of 78.69M, resulting in an operating margin of -1.0%.

HRMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a net income of 32.49M and revenue of 215.39M, resulting in a net margin of 15.1%.

CTLP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cantaloupe, Inc. reported a net income of -2.16M and revenue of 78.69M, resulting in a net margin of -2.7%.

Frequently Asked Questions

Can I hold both HRMY and CTLP in my portfolio?

HRMY and CTLP have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.